We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$101M |
| 2 |
GE Vernova
GEV
|
+$75.4M |
| 3 |
CRH
CRH
|
+$48.5M |
| 4 |
CrowdStrike
CRWD
|
+$45.8M |
| 5 |
Dell
DELL
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$180M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$59.1M |
| 4 |
UnitedHealth
UNH
|
+$46.6M |
| 5 |
NVIDIA
NVDA
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Financials | 12.55% |
| 3 | Healthcare | 11.48% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SHYF
2426
DELISTED
The Shyft Group
SHYF
| $640K | ﹤0.01% |
53,987
+7,050
| +15% | +$84.7K |
|
2427
Corbus Pharmaceuticals
CRBP
$190M
| $638K | ﹤0.01% |
+14,103
| New | +$593K |
|
|
NFBK
2428
DELISTED
Northfield Bancorp
NFBK
| $638K | ﹤0.01% |
67,306
-63,228
| -48% | -$554K |
|
|
NBIS
2429
Nebius Group N.V.
NBIS
$47.7B
| $638K | ﹤0.01% |
33,667
| – | – |
|
2430
UWM Holdings
UWMC
$434M
| $637K | ﹤0.01% |
91,964
+3,426
| +4% | +$23.5K |
|
2431
InterContinental Hotels
IHG
$23.2B
| $637K | ﹤0.01% |
6,011
-57
| -0.9% | -$5.77K |
|
2432
Tiptree Inc
TIPT
$675M
| $636K | ﹤0.01% |
38,566
+1,977
| +5% | +$33.1K |
|
|
LAZR
2433
DELISTED
Luminar Technologies
LAZR
| $636K | ﹤0.01% |
28,444
+3,664
| +15% | +$86.8K |
|
2434
Bar Harbor Bankshares
BHB
$666M
| $634K | ﹤0.01% |
23,569
+152
| +0.6% | +$3.89K |
|
2435
Logitech
LOGI
$15.2B
| $633K | ﹤0.01% |
6,529
-294
| -4% | -$26.5K |
|
|
MCBC
2436
DELISTED
Macatawa Bank Corp
MCBC
| $632K | ﹤0.01% |
43,258
-10,353
| -19% | -$138K |
|
2437
Perspective Therapeutics
CATX
$342M
| $630K | ﹤0.01% |
+63,170
| New | +$913K |
|
2438
TFS Financial
TFSL
$4.93B
| $629K | ﹤0.01% |
49,865
-5,242
| -10% | -$66K |
|
2439
Wave Life Sciences
WVE
$1.2B
| $628K | ﹤0.01% |
125,834
+4,092
| +3% | +$23.3K |
|
|
KALV
2440
DELISTED
KalVista Pharmaceuticals
KALV
| $627K | ﹤0.01% |
53,228
+5,908
| +12% | +$68.9K |
|
|
APLT
2441
DELISTED
Applied Therapeutics
APLT
| $625K | ﹤0.01% |
133,895
+133,351
| +24,513% | +$631K |
|
|
HDSN
2442
Hudson Technologies
HDSN
$235M
| $624K | ﹤0.01% |
70,982
+1,770
| +3% | +$17.2K |
|
2443
FRP Holdings
FRPH
$421M
| $622K | ﹤0.01% |
21,814
+138
| +0.6% | +$4.13K |
|
2444
Annexon
ANNX
$886M
| $621K | ﹤0.01% |
126,659
+44,681
| +55% | +$231K |
|
2445
Global Industrial
GIC
$1.49B
| $619K | ﹤0.01% |
19,749
+397
| +2% | +$14.5K |
|
2446
Peapack-Gladstone Financial
PGC
$812M
| $619K | ﹤0.01% |
27,311
+272
| +1% | +$6.17K |
|
2447
MaxCyte
MXCT
$126M
| $618K | ﹤0.01% |
157,616
+20,864
| +15% | +$89.8K |
|
2448
Treace Medical Concepts
TMCI
$309M
| $617K | ﹤0.01% |
92,849
+31,281
| +51% | +$253K |
|
|
HLVX
2449
DELISTED
HilleVax
HLVX
| $617K | ﹤0.01% |
42,658
+9,073
| +27% | +$125K |
|
2450
Fortis
FTS
$28.7B
| $616K | ﹤0.01% |
15,866
-1,706
| -10% | -$67.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2024 Portfolio in Review
As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
- RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
- RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
- RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
- RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.
Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.